Found 52 Vision Loss trials
A listing of Vision Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The trial will enroll subjects who have had an inadequate response (IR) to prior biologic therapy (bio-IR). The bio-IR population is defined as subjects with documented intolerance or inadequate response to one or more of the approved biologics for UC (infliximab, adalimumab, golimumab, and/or vedolizumab).
The purpose of this study is to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT).
A study to investigate efficacy and safety of OG-6219 BID in 3 dose levels compared with Placebo in participants aged 18 to 49 with moderate to severe endometriosis-related pain
The study is intended to show superiority of AZD9833 in combination with CDK4/6 inhibitor (palbociclib or abemaciclib) versus aromatase inhibitors (anastrozole or letrozole) in combination with CDK4/6 inhibitor in patients with hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative) metastatic breast cancer with detectable ESR1 mutation
The purpose of this study is to learn more about eosinophilic granulomatosis with polyangiitis (EGPA) that returns (relapse) or has not responded to treatment, and if the investigational drug depemokimab can improve the disease. This study is being done to help determine if depemokimab is safe and how it works …
The main purpose of this study is to learn how well the investigational drug NS-229 works and how safe NS-229 is compared with placebo. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA) to treat EGPA. Participants could be in the …
This protocol is to see the affects of different combination therapy of Pozelimab and Cemdisiran in patient's with Symptomatic generalized myasthenia gravis. The study is split into 5 different parts: Screening. randomization and double blind study treatment period, double blind extension study treatment period, open-label study treatment period, and follow …
A Long-Term Extension study for patients who have completed the double-blind treatment trial ABC008-IBM-201. The primary objective is to assess the long-term safety and tolerability of ulviprubart (ABC008) in subjects with Inclusion Body Myositis, as well as to assess long-term efficacy using a standardized weight-based dose (2.0 mg/kg) previously evaluated …
Study A35-009 is a two-phase study to evaluate the efficacy and safety of AMX0035 in participants with PSP, consisting of a randomized, double-blind, placebo-controlled phase followed by an optional open-label extension (OLE) phase. The double-blind phase of the study consists of a Screening Period of up to 6 weeks, a …
This is a Phase II, double-blind, sham controlled, randomized, crossover, multisite clinical trial investigating the effectiveness of transcranial direct current stimulation (tDCS) coupled with naming and spelling therapy (NASP) to improve language in people with primary progressive aphasia (PPA).
